Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-129723
Filing Date
2019-04-30
Accepted
2019-04-30 17:14:04
Documents
4
Period of Report
2019-06-26
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d664711ddef14a.htm DEF 14A 897604
2 GRAPHIC g664711dsp001.jpg GRAPHIC 293750
3 GRAPHIC g664711dsp002.jpg GRAPHIC 187254
4 GRAPHIC g664711g16y78.jpg GRAPHIC 28370
  Complete submission text file 0001193125-19-129723.txt   1600488
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50768 | Film No.: 19783120
SIC: 2834 Pharmaceutical Preparations